
Benzinga Pro data, BioCardia (NASDAQ:BCDA) reported Q4 sales of $79.00 thousand. Earnings fell to a loss of $3.46 million, resulting in a 27.9% decrease from last quarter. BioCardia collected $821.00 thousand in revenue during Q3, but reported earnings showed a $2.71 million loss.